Condition: Von Willebrand Diseases · Sponsor: Vega Therapeutics, Inc
The VIVID study is structured in a master protocol format comprised of multiple parts that evaluate intravenous (IV) and subcutaneous (SC) VGA039 in healthy volunteers and subjects with von Willebrand Disease (VWD) and other bleeding disorders.
This description comes directly from the study's public registry record.
Clinical Trials · 650-466-8041 · medinfo@star-therapeutics.com
Always discuss trial participation with your own doctor first.
| Orthopedic Institute for Children (UCLA) | Los Angeles, California, United States | Recruiting |
| UC Davis Medical Center | Sacramento, California, United States | Recruiting |
| University of Colorado School of Medicine | Aurora, Colorado, United States | Recruiting |
| Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory | Atlanta, Georgia, United States | Recruiting |
| Science 37, Inc. | Morrisville, North Carolina, United States | Recruiting |
| Hemophilia Center of Western PA | Pittsburgh, Pennsylvania, United States | Recruiting |
| Vanderbilt University Medical Center | Nashville, Tennessee, United States | Recruiting |
| University of Texas Southwestern | Dallas, Texas, United States | Recruiting |
| Washington Center for Bleeding Disorders | Seattle, Washington, United States | Recruiting |
| Versiti Comprehensive Center for Bleeding Disorders | Milwaukee, Wisconsin, United States | Recruiting |
| Royal Brisbane & Women's Hospital, Queensland Haemophilia Centre | Herston, Queenland, Australia | Recruiting |
| Medical University of Vienna | Vienna, State of Vienna, Austria | Completed |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05776069